Culture technology and quality control support for skin, corneas and conjunctiva provided by overseas specialists
First written in FY2021-Q1. 2 of 5 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024DroppedAnnual reportThe FY2024 main text does not identify a standalone theme concerning an agreement for support from overseas experts on culture technology for skin, corneas and conjunctiva and quality control.
- FY2023-Q1RestatedAnnual report
「Michele De Luca, M.D., provided the Company with advice on the culture technology for skin and corneas and quality control of cultured products, and the Company paid Michele De Luca, M.D., consideration for those services. Graziella Pellegrini, Ph.D., provided the Company with advice on the culture technology for skin, corneas and conjunctiva and quality control of cultured products, and the Company paid Graziella Pellegrini, Ph.D., consideration for those services.」
The Company continued its agreements with overseas experts from April 2022 to March 2023 for advice on culture technology for skin, corneas and conjunctiva and quality control. - FY2022AdvancedAnnual report
「Contract title CONSULTING CONTRACT Counterparty Michele De Luca Contract date 13 May 2022 Contract period 1 April 2022 to 31 March 2023 Key terms Michele De Luca, M.D., provided the Company with advice on the culture technology for skin and corneas and quality control of cultured products, and the Company paid Michele De Luca, M.D., consideration for those services.」
The Company entered into a renewal agreement covering the period from April 2022 to March 2023 for the consulting agreement with an overseas expert that expired on 31 March 2022. - FY2022-Q1AdvancedAnnual report
「Contract period: 1 April 2021 to 31 March 2022. Michele De Luca, M.D., provided the Company with advice on the culture technology for skin and corneas and quality control of cultured products, and the Company paid Michele De Luca, M.D., consideration for those services.」
The consulting agreement with overseas experts on culture technology for skin, corneas and conjunctiva and quality control was renewed for the period from April 2021 to March 2022. - FY2021-Q1First statedAnnual report
「Contract period: 1 April 2020 to 31 March 2021. Michele De Luca, M.D., provided the Company with advice on the culture technology for skin and corneas and quality control of cultured products, and the Company paid Michele De Luca, M.D., consideration for those services. Graziella Pellegrini, Ph.D., provided the Company with advice on the culture technology for skin, corneas and conjunctiva and quality control of cultured products, and the Company paid Graziella Pellegrini, Ph.D., consideration for those services.」
The Company disclosed a consulting agreement under which it received advice from overseas experts on culture technology for skin, corneas and conjunctiva and quality control of cultured products. The agreement was a renewal of the 2019 agreement.